Movement Alert｜Asymchem Laboratories Rises 6.76% in Regular Trading, Pharma Outsourcing Sector Momentum Continues

Market Focus13:04

On July 10, Asymchem Laboratories (06821.HK) rose 6.76% in regular trading, trading at HK$122.1/share, with turnover of HK$89.6 million. The gain follows a 7.82% surge in its A-share counterpart on July 9, reflecting continued momentum in the pharmaceutical outsourcing sector.

The rally comes amid multiple positive signals. The company recently stated on its investor relations platform that overseas market expansion is expected to enhance revenue growth and profitability. Separately, a major brokerage maintained a Buy rating on the stock with projected net profits of RMB 1.507/1.859/2.312 billion for the coming three years, citing high-quality revenue and profit growth driven by multi-track resonance. Additionally, another research house recommended Asymchem as a top pick among high-growth CRO names with attractive valuation.

Within the Pharmaceuticals sector, the overall tone was positive. Among individual stocks, CSPC Pharma up 5.74%, SBP Group up 5.20%, Hengrui Pharma up 3.16%, Hansoh Pharma up 3.08%, and Luye Pharma up 2.09%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1138132122?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-10 13:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1138132122","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Asymchem Laboratories Rises 6.76% in Regular Trading, Pharma Outsourcing Sector Momentum Continues","media":"Market Focus","content":"<p><p>On July 10, Asymchem Laboratories (06821.HK) rose 6.76% in regular trading, trading at HK$122.1/share, with turnover of HK$89.6 million. The gain follows a 7.82% surge in its A-share counterpart on July 9, reflecting continued momentum in the pharmaceutical outsourcing sector.</p><p>The rally comes amid multiple positive signals. The company recently stated on its investor relations platform that overseas market expansion is expected to enhance revenue growth and profitability. Separately, a major brokerage maintained a Buy rating on the stock with projected net profits of RMB 1.507/1.859/2.312 billion for the coming three years, citing high-quality revenue and profit growth driven by multi-track resonance. Additionally, another research house recommended Asymchem as a top pick among high-growth CRO names with attractive valuation.</p><p>Within the Pharmaceuticals sector, the overall tone was positive. Among individual stocks, CSPC Pharma up 5.74%, SBP Group up 5.20%, Hengrui Pharma up 3.16%, Hansoh Pharma up 3.08%, and Luye Pharma up 2.09%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Asymchem Laboratories Rises 6.76% in Regular Trading, Pharma Outsourcing Sector Momentum Continues</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Asymchem Laboratories Rises 6.76% in Regular Trading, Pharma Outsourcing Sector Momentum Continues\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-10 13:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 10, Asymchem Laboratories (06821.HK) rose 6.76% in regular trading, trading at HK$122.1/share, with turnover of HK$89.6 million. The gain follows a 7.82% surge in its A-share counterpart on July 9, reflecting continued momentum in the pharmaceutical outsourcing sector.</p><p>The rally comes amid multiple positive signals. The company recently stated on its investor relations platform that overseas market expansion is expected to enhance revenue growth and profitability. Separately, a major brokerage maintained a Buy rating on the stock with projected net profits of RMB 1.507/1.859/2.312 billion for the coming three years, citing high-quality revenue and profit growth driven by multi-track resonance. Additionally, another research house recommended Asymchem as a top pick among high-growth CRO names with attractive valuation.</p><p>Within the Pharmaceuticals sector, the overall tone was positive. Among individual stocks, CSPC Pharma up 5.74%, SBP Group up 5.20%, Hengrui Pharma up 3.16%, Hansoh Pharma up 3.08%, and Luye Pharma up 2.09%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06821","symbol_name":"凯莱英","start_time":0,"source_url":"","article_id":"1138132122","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1138132122","pubTimestamp":1783659854,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 10, Asymchem Laboratories (06821.HK) rose 6.76% in regular trading, trading at HK$122.1/share, with turnover of HK$89.6 million. The gain follows a 7.82% surge in its A-share counterpart on...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06821":"凯莱英"},"translate_title":"走势提醒|凯莱英制药常规交易上涨6.76%，医药外包板块势头持续","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06821":1},"content_text":"On July 10, Asymchem Laboratories (06821.HK) rose 6.76% in regular trading, trading at HK$122.1/share, with turnover of HK$89.6 million. The gain follows a 7.82% surge in its A-share counterpart on July 9, reflecting continued momentum in the pharmaceutical outsourcing sector.The rally comes amid multiple positive signals. The company recently stated on its investor relations platform that overseas market expansion is expected to enhance revenue growth and profitability. Separately, a major brokerage maintained a Buy rating on the stock with projected net profits of RMB 1.507/1.859/2.312 billion for the coming three years, citing high-quality revenue and profit growth driven by multi-track resonance. Additionally, another research house recommended Asymchem as a top pick among high-growth CRO names with attractive valuation.Within the Pharmaceuticals sector, the overall tone was positive. Among individual stocks, CSPC Pharma up 5.74%, SBP Group up 5.20%, Hengrui Pharma up 3.16%, Hansoh Pharma up 3.08%, and Luye Pharma up 2.09%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1138132122","isCrawlerRequest":true}